These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36058050)

  • 1. First trimester serum biomarker discovery study for early onset, preterm onset and preeclampsia at term.
    Beernink RHJ; Zwertbroek EF; Schuitemaker JHN; Cremers TIFH; Scherjon SA
    Placenta; 2022 Oct; 128():39-48. PubMed ID: 36058050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
    Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia.
    Gál L; Fóthi Á; Orosz G; Nagy S; Than NG; Orbán TI
    Front Immunol; 2024; 15():1321191. PubMed ID: 38455065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second- and third-trimester serum levels of growth-differentiation factor-15 in prediction of pre-eclampsia.
    Wertaschnigg D; Rolnik DL; Nie G; Teoh SSY; Syngelaki A; da Silva Costa F; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Dec; 56(6):879-884. PubMed ID: 32388891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia.
    Lee SM; Kang Y; Lee EM; Jung YM; Hong S; Park SJ; Park CW; Norwitz ER; Lee DY; Park JS
    Sci Rep; 2020 Sep; 10(1):16142. PubMed ID: 32999354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
    Dobierzewska A; Soman S; Illanes SE; Morris AJ
    PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia.
    Santos LL; Wertaschnigg D; Rolnik DL; Da Silva Costa F; Syngelaki A; Dimitriadis E; Nicolaides KH
    Placenta; 2021 Jan; 103():76-81. PubMed ID: 33099202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein profile analysis via label-free quantitation proteomics in patients with early-onset preeclampsia.
    Ji Q; Zhang S; Jiang W; Wang J; Luan Y; Xin Q
    J Obstet Gynaecol; 2023 Dec; 43(2):2259982. PubMed ID: 37743728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
    Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
    Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating pregnancy hormone relaxin as a first trimester biomarker for preeclampsia.
    Post Uiterweer ED; Koster MPH; Jeyabalan A; Kuc S; Siljee JE; Stewart DR; Conrad KP; Franx A
    Pregnancy Hypertens; 2020 Oct; 22():47-53. PubMed ID: 32738589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
    Mach P; Nolte-Boenigk L; Droste L; Fox L; Frank M; Schmidt B; Herse F; Verlohren S; Wicherek L; Iannaccone A; Birdir C; Andrikos D; Kimmig R; Gellhaus A; Köninger A
    Am J Reprod Immunol; 2018 Sep; 80(3):e12988. PubMed ID: 29797540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester mean arterial blood pressure and the risk of preeclampsia: The Great Obstetrical Syndromes (GOS) study.
    Gasse C; Boutin A; Coté M; Chaillet N; Bujold E; Demers S
    Pregnancy Hypertens; 2018 Apr; 12():178-182. PubMed ID: 29175170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study.
    Starodubtseva N; Tokareva A; Kononikhin A; Brzhozovskiy A; Bugrova A; Kukaev E; Muminova K; Nakhabina A; Frankevich VE; Nikolaev E; Sukhikh G
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39408980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.